A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Boston Children's Hospital
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Thomas Jefferson University
Baylor College of Medicine
Incyte Corporation
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Duke University
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Fadoi Foundation, Italy
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
City of Hope Medical Center
Thomas Jefferson University
Fred Hutchinson Cancer Center
AstraZeneca
Fred Hutchinson Cancer Center
Ottawa Hospital Research Institute
Merck Sharp & Dohme LLC
Stanford University
IGF Oncology, LLC
Medical College of Wisconsin
National Cancer Institute (NCI)
University of California, San Diego
Memorial Sloan Kettering Cancer Center
AstraZeneca
City of Hope Medical Center
Virginia Commonwealth University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Alliance Foundation Trials, LLC.
Bellicum Pharmaceuticals
Sobi, Inc.
M.D. Anderson Cancer Center
Bellicum Pharmaceuticals
Merck Sharp & Dohme LLC
Celgene
OHSU Knight Cancer Institute
Alexion Pharmaceuticals, Inc.